Quarterly report pursuant to Section 13 or 15(d)

Intangibles, net (Narrative) (Details)

v3.22.1
Intangibles, net (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dermira, Inc. a subsidiary of Eli Lilly [Member]    
Finite-Lived Intangible Assets [Line Items]    
Payments of milestones $ 7.5  
Journey [Member]    
Finite-Lived Intangible Assets [Line Items]    
Payments of milestones 10.0  
Amortization of intangible assets $ 1.0 $ 0.6
Minimum [Member] | Journey [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, estimated useful lives 3 years  
Maximum [Member] | Journey [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, estimated useful lives 9 years